Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages 3216-3223

  Gaudet, Mia M ^a   Falk, Roni T ^b   Stevens, Robert D ^c   Gunter, Marc J ^d   Bain, James R ^c   Pfeiffer, Ruth M ^b   Potischman, Nancy ^b   Lissowska, Jolanta ^e   Peplonska, Beata ^f   Brinton, Louise A ^b   Garcia Closas, Montserrat ^b   Newgard, Christopher B ^c   Sherman, Mark E ^b  

^a AMERICAN CANCER SOCIETY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e INSTITUTE OF ONCOLOGY   (Poland)

^f NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; AMINO ACID; DECATRIENOYLCARNITINE; FATTY ACID; LINOLEIC ACID; OCTENOYL CARNITINE; OLEIC ACID; PALMITIC ACID; STEARIC ACID; UNCLASSIFIED DRUG; VALINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY MASS; BODY SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; METABOLITE; OUTCOME ASSESSMENT; PATHOGENESIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; STUDY DESIGN;

ADULT; AGED; AGING; ALGORITHMS; AMINO ACIDS; BODY MASS INDEX; BODY WEIGHT; CARNITINE; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; ENDOMETRIAL NEOPLASMS; FATTY ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLAND; POPULATION; QUALITY CONTROL;

EID: 84866162860     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1490     Document Type: Article

References (36)

1. GLOBOCAN 2008 Cancer incidence, mortality and prevalence worldwide in 2008. Lyon, France: International Agency for Research on Cancer
2. Kaaks R, Lukanova A, Kurzer MS 2002 Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11:1531-1543 (Pubitemid 36020003)
3. Després JP, Lemieux I 2006 Abdominal obesity and metabolic syndrome. Nature 444:881-887 (Pubitemid 46024995)
4. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET 2004 Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89:2569-2575 (Pubitemid 38766333)
5. Cust AE, Allen NE, Rinaldi S, Dossus L, Friedenreich C, Olsen A, Tjonneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Chang-Claude J, Boeing H, Schulz M, Benetou V, Trichopoulou A, Trichopoulos D, Palli D, Berrino F, Tumino R, Mattiello A, Vineis P, Quirós JR, Agudo A, Sanchez MJ, Larrañaga N, Navarro C, Ardanaz E, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Bingham S, Khaw KT, Key T, Slimani N, Riboli E, Kaaks R 2007 Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. Int J Cancer 120:2656-2664 (Pubitemid 46651288)
6. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Manson JE, Li J, Harris TG, Rohan TE, Xue X, Ho GY, Einstein MH, Kaplan RC, Burk RD, Wylie-Rosett J, Pollak MN, Anderson G, Howard BV, Strickler HD 2008 A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev 17:921-929 (Pubitemid 351536424)
7. Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R 2004 Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 108:262-268 (Pubitemid 37541781)
8. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, Peeters PH, Onland-Moret NC, Lahmann PH, Berrino F, Panico S, Larrañaga N, Pera G, Tormo MJ, Sánchez MJ, Ramón Quirós J, Ardanaz E, Tjønneland A, Olsen A, Chang-Claude J, Linseisen J, Schulz M, Boeing H, Lundin E, Palli D, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Bingham S, Khaw KT, Bueno-de-Mesquita HB, Trichopoulou A, Trichopoulos D, Naska A, Tumino R, Riboli E, Kaaks R 2008 Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 15:485-497 (Pubitemid 351880837)
9. Zeleniuch-Jacquotte A, Akhmedkhanov A, Kato I, Koenig KL, Shore RE, Kim MY, Levitz M, Mittal KR, Raju U, Banerjee S, Toniolo P 2001 Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer 84:975-981 (Pubitemid 32385843)
10. Zeleniuch-Jacquotte A, Shore RE, Afanasyeva Y, Lukanova A, Sieri S, Koenig KL, Idahl A, Krogh V, Liu M, Ohlson N, Muti P, Arslan AA, Lenner P, Berrino F, Hallmans G, Toniolo P, Lundin E 2011 Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer. Br J Cancer 105:1458-1464
11. Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Lukanova A, Rinaldi S, Dossus L, Slimani N, Lundin E, Tjønneland A, Olsen A, Overvad K, Clavel-Chapelon F, Mesrine S, Joulin V, Linseisen J, Rohrmann S, Pischon T, Boeing H, Trichopoulos D, Trichopoulou A, Benetou V, Palli D, Berrino F, Tumino R, Sacerdote C, Mattiello A, Quirós JR, Mendez MA, Sánchez MJ, Larrañaga N, Tormo MJ, Ardanaz E, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Khaw KT, Bingham S, Allen N, Key T, Jenab M, Riboli E 2007 Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab 92:255-263 (Pubitemid 46067541)
12. Soliman PT, Cui X, Zhang Q, Hankinson SE, Lu KH 2011 Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study. Am J Obstet Gynecol 204:167.e161-167.e165
13. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy Jr WS, Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP 2009 A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311-326
14. Huffman KM, Shah SH, Stevens RD, Bain JR, Muehlbauer M, Slentz CA, Tanner CJ, Kuchibhatla M, Houmard JA, Newgard CB, Kraus WE 2009 Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 32:1678-1683
15. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O'Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE 2011 Metabolite profiles and the risk of developing diabetes. Nat Med 17:448-453
16. Laferrere B, Reilly D, Arias S, Swerdlow N, Gorroochurn P, Bawa B, Bose M, Teixeira J, Stevens RD, Wenner BR, Bain JR, Muehlbauer MJ, Haqq A, Lien L, Shah SH, Svetkey LP, Newgard CB 2011 Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med 3:80re82
17. Tai ES, Tan ML, Stevens RD, Low YL, Muehlbauer MJ, Goh DL, Ilkayeva OR, Wenner BR, Bain JR, Lee JJ, Lim SC, Khoo CM, Shah SH, Newgard CB 2010 Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 53:757-767
18. Brinton LA, Sakoda LC, Lissowska J, Sherman ME, Chatterjee N, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M 2007 Reproductive risk factors for endometrial cancer among Polish women. Br J Cancer 96:1450-1456 (Pubitemid 46685791)
19. García-Closas M, Brinton LA, Lissowska J, Chatterjee N, Peplonska B, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Blair A, Kalaylioglu Z, Rymkiewicz G, Mazepa-Sikora D, Kordek R, Lukaszek S, Sherman ME 2006 Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer 95:123-129 (Pubitemid 43980566)
20. Lien LF, Haqq AM, Arlotto M, Slentz CA, Muehlbauer MJ, McMahon RL, Rochon J, Gallup D, Bain JR, Ilkayeva O, Wenner BR, Stevens RD, Millington DS, Muoio DM, Butler MD, Newgard CB, Svetkey LP 2009 The STEDMAN project: biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain. OMICS 13:21-35
21. Emken EA 1994 Metabolism of dietary stearic acid relative to other fatty acids in human subjects. Am J Clin Nutr 60:1023S-1028S
22. Katan MB, Zock PL, Mensink RP 1994 Effects of fats and fatty acids on blood lipids in humans: an overview. Am J Clin Nutr 60:1017S-1022S
23. Hunter JE, Zhang J, Kris-Etherton PM 2010 Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 91:46-63
24. Saadatian-Elahi M, Norat T, Goudable J, Riboli E 2004 Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int J Cancer 111:584-591 (Pubitemid 39045326)
25. Rissanen H, Knekt P, Järvinen R, Salminen I, Hakulinen T 2003 Serum fatty acids and breast cancer incidence. Nutr Cancer 45:168-175 (Pubitemid 37022789)
26. Ferrara F, Bertelli A, Falchi M 2005 Evaluation of carnitine, acetylcarnitine and isovalerylcarnitine on immune function and apoptosis. Drugs Exp Clin Res 31:109-114 (Pubitemid 40942952)
27. Pontremoli S, Melloni E, Viotti PL, Michetti M, Di Lisa F, Siliprandi N1990 Isovalerylcarnitine is a specific activator of the high calcium requiring calpain forms. Biochem Biophys Res Commun 167:373-380 (Pubitemid 20085394)
28. Pontremoli S, Melloni E, Michetti M, Sparatore B, Salamino F, Siliprandi N, Horecker BL 1987 Isovalerylcarnitine is a specific activator of calpain of human neutrophils. Biochem Biophys Res Commun 148:1189-1195 (Pubitemid 18074655)
29. Welsch CW 1992 Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res 52:2040s-2048s
30. Potischman N, Swanson CA, Brinton LA, McAdams M, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Hoover RN 1993 Dietary associations in a case-control study of endometrial cancer. Cancer Causes Control 4:239-250 (Pubitemid 23149539)
31. Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, Weiss NS 2008 Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am J Epidemiol 168:563-570; discussion 571-576
32. Yang HP, Brinton LA, Platz EA, Lissowska J, Lacey Jr JV, Sherman ME, Peplonska B, Garcia-Closas M 2010 Active and passive cigarette smoking and the risk of endometrial cancer in Poland. Eur J Cancer 46:690-696
33. Gika HG, Theodoridis GA, Wingate JE, Wilson ID 2007 Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J Proteome Res 6:3291-3303 (Pubitemid 47310213)
34. Sangster T, Major H, Plumb R, Wilson AJ, Wilson ID 2006 A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst 131:1075-1078 (Pubitemid 44465534)
35. Walsh MC, Brennan L, Malthouse JP, Roche HM, Gibney MJ 2006 Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr 84:531-539 (Pubitemid 44713402)
36. Bictash M, Ebbels TM, Chan Q, Loo RL, Yap IK, Brown IJ, de Iorio M, Daviglus ML, Holmes E, Stamler J, Nicholson JK, Elliott P 2010 Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology. J Clin Epidemiol 63:970-979